Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Exploratory Clinical Study of GC012F Injection in Refractory Idiopathic Inflammatory Myopathy

NCT07086404 is registered in ClinicalTrials.gov with Daishi Tian as lead sponsor.

NCT NCT07086404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07086404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Exploratory Clinical Study of GC012F Injection in Refractory Idiopathic Inflammatory Myopathy
Lead sponsor
Daishi Tian
Phase
Phase 1
Overall status
Recruiting
Start date
September 15, 2025
Completion date
September 15, 2029
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic inflammatory myopathy (iim)